跳至主要内容
临床试验/NCT06991205
NCT06991205招募中不适用

Feasibility RCT of Web-based Mind-body Treatment to Enhance Resilience Among Patients With Painful Nontraumatic Upper-extremity Conditions and Commorbid Risky Substance Use

Jafar Bakhshaie1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年9月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Rate at which program was accepted, measured by attendance to assess acceptability of treatment

研究概览

简要总结

The investigator aims to conduct a feasibility randomized controlled trial (RCT) (N=50) to test the feasibility, acceptability, and credibility of an asynchronous web-based mind-body intervention (Toolkit for Resilient Life beyond Pain and Substance Use; Web-TIRELESS) versus web-based minimally enhanced usual care (Web-MEUC) among adult patients with a painful non-traumatic upper-extremity condition(s) (PNUC) and commorbid risky substance use.

Deliverables: [1] Adapt and refine open pilot protocol, patient recruitment, and other study materials. [2] Assess the feasibility, acceptability, and credibility of Web-TIRELESS and Web-MEUC in preparation for future research.

详细描述

Aim: Conduct a feasibility randomized controlled trial (RCT) (N=50) of Web-TIRELESS versus Minimally Enhanced Usual Care (Web-MEUC)-both of which are web-based-among patients with painful nontraumatic upper extremity conditions and comorbid risky substance use (N=50), to demonstrate the feasibility of recruitment procedures and data collection; and the feasibility, credibility, and acceptability (adherence, retention, fidelity, and satisfaction) of Web-TIRELESS and Web-MEUC. We will use this mixed-methods information to assess the primary outcomes and optimize both programs and study methodology in preparation for research.

Participants are randomized to either Web-TIRELESS or Web-MEUC and given access to the respective program for approximately 5 weeks to review and complete the assigned material. Both groups are given education material to help improve pain and substance use urge coping. There are 3 assessment points consisting of self-report surveys: baseline, post-program, and 6-month follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Outpatient adults seeking care in the Hand and Arm Center
  • •Diagnosed with a non-traumatic painful upper-extremity condition (NPUC)
  • •Pain score > 4 on the Numerical Rating Scale (NRS)
  • •Risky substance use (scores >10 and <27 for alcohol, and >3 and <27 for cannabis, cocaine, amphetamine-type stimulants, inhalants, sedatives, hallucinogens, opioids, tobacco products, and e-cigarette on The World Health Organization's - Alcohol, Smoking and Substance Involvement Screening Test [WHO-ASSIST])
  • •Owns a smartphone, laptop, or computer with internet access
  • •English fluency
  • •Ability and willingness to participate in a live video focus group and the following asynchronous Web-based intervention

排除标准

  • •Participation in mind-body or specialized substance abuse treatment in the past 3 months
  • •Practice of mindfulness >45 minutes/week in the past 3 months
  • •Psychotropic medications (e.g. antidepressants) changed in the past 3 months
  • •Serious untreated mental illness (e.g., Schizophrenia)
  • •Suicidal ideation with intent or plan
  • •Secondary gains that may bias motivation (e.g., pending disability claim),
  • •Moderate to severe cognitive impairment (score ≥4 on the Short Portable Mental Status Questionnaire (SPMSQ))
  • •History of surgery for the presented NPUC within the past 6 months OR future plans for surgery.

研究组 & 干预措施

Web-TIRELESS

Experimental

A 4-session, asynchronous, web-based mind-body pain and substance use management intervention.

干预措施: Web-TIRELESS (Behavioral)

Web-MEUC

Active Comparator

Open access to a web-based pamphlet containing brief, educational information and coping techniques.

干预措施: Web-MEUC (Other)

结局指标

主要结局

Rate at which program was accepted, measured by attendance to assess acceptability of treatment

时间窗: Post-Test (5 Weeks)

The proportion of Web-TIRELESS participants who complete \> or = 3 of 4 sessions.

The percent of patients that agree to participate to assess feasibility of recruitment

时间窗: Baseline (0 Weeks)

The percent of eligible patients approached that agree to participate.

Adherence to homework

时间窗: Throughout intervention completion, an average of 1 month

Rate of Web-TIRELESS participant's completion of homework assigned throughout the study.

Adverse Events

时间窗: Throughout intervention completion, an average of 1 month

Any self-reported or observed negative events related to participation.

Rate of participant's completion of self-report measures to assess feasibility of assessments

时间窗: Baseline (0 Weeks), Post-Test (5 Weeks)

Investigators will report number of patients who complete assessments at each time-point.

Credibility and Expectancy Questionnaire (CEQ)

时间窗: Baseline (0 Weeks)

Assesses the degree to which one believes the intervention will effectively manage their condition, substance use, and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.

Client Satisfaction Questionnaire to assess satisfaction with/acceptability of treatment

时间窗: Post-Test (5 Weeks)

Participants' satisfaction with treatment received after completion. The score range is 0-12. Higher scores indicate greater satisfaction.

The User Experience Scale to assess participants' satisfaction with (acceptability of) web-based delivery

时间窗: Post-Test (5 Weeks)

This measure will assess how well patients like the Wed-based program content and delivery. Total raw scores range from 22 to 110 with higher scores indicating greater satisfaction with the platform.

次要结局

  • PROMIS Emotional Distress - Anxiety-Short Form 8a v1.0(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Pain Catastrophizing Scale (PCS)(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Graded Chronic Pain Scale (GCPS)(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Disabilities of the Arm, Shoulder and Hand (DASH)(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Patient Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Depression-Short Form 8a v1.0(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Pain Anxiety Symptoms Scale - Short Form (PASS-20)(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Pain Vigilance and Awareness Questionnaire (PVAQ)(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Brief Experiential Avoidance Questionnaire (BEAQ)(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • Current Opioid Misuse Measure (COMM)(Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months))
  • The Timeline Follow Back (TLFB)(Throughout intervention completion, an average of 1 month)
  • Numerical Rating Scale (NRS)(Eligibility Screening (-1 Weeks))

研究者

发起方
Jafar Bakhshaie
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jafar Bakhshaie

Principal Investigator

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验